CHRISTINA PAUDA: Open Payments
NPI 1750093779 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,547 in 76 payments from 9 companies in 2025. Trend: 2023 $1,683 · 2024 $1,916 · 2025 $1,547
Food & beverage: $1,493Education: $54
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 26 | $487 |
| ABBVIE INC. | 14 | $290 |
| AstraZeneca Pharmaceuticals LP | 8 | $192 |
| GlaxoSmithKline, LLC. | 10 | $185 |
| E.R. Squibb & Sons, L.L.C. | 5 | $117 |
| Novartis Pharmaceuticals Corporation | 5 | $98 |
| PFIZER INC. | 3 | $67 |
| Janssen Biotech, Inc. | 3 | $58 |
| UCB, Inc. | 2 | $52 |
Products named: KRYSTEXXA, SAPHNELO, BENLYSTA, SKYRIZI, TAVNEOS, ORENCIA, RINVOQ, COSENTYX.
Industry payments across TX — which companies pay providers there.
